HSIC - Henry Schein, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
69.56
+0.87 (+1.27%)
As of 1:25PM EST. Market open.
Stock chart is not supported by your current browser
Previous close68.69
Open68.89
Bid69.53 x 900
Ask69.56 x 2900
Day's range68.75 - 69.64
52-week range56.58 - 72.81
Volume326,909
Avg. volume1,038,220
Market cap10.207B
Beta (3Y monthly)0.78
PE ratio (TTM)21.00
EPS (TTM)3.31
Earnings date18 Feb 2020 - 24 Feb 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est68.27
  • Have Henry Schein, Inc. (NASDAQ:HSIC) Insiders Been Selling Their Stock?
    Simply Wall St.

    Have Henry Schein, Inc. (NASDAQ:HSIC) Insiders Been Selling Their Stock?

    We'd be surprised if Henry Schein, Inc. (NASDAQ:HSIC) shareholders haven't noticed that an insider, Paul Brons...

  • Henry Schein (HSIC) Q3 Earnings Top Estimates, Revenues Lag
    Zacks

    Henry Schein (HSIC) Q3 Earnings Top Estimates, Revenues Lag

    Henry Schein (HSIC) registers solid performance across its key operating businesses in Q3.

  • Business Wire

    Henry Schein Reports Record Third Quarter 2019 Financial Results From Continuing Operations

    "We continue to make progress in growing organically with a focus on sales of higher-margin products while making strategic investments to supplement growth in the years ahead."

  • Medical Products' Earnings Roster for Nov 5: BDX, ZBH & More
    Zacks

    Medical Products' Earnings Roster for Nov 5: BDX, ZBH & More

    Encouraging growth in the emerging markets despite the ongoing Sino-US trade tensions is likely to favor revenues in the medical products space this earnings season.

  • Do You Like Henry Schein, Inc. (NASDAQ:HSIC) At This P/E Ratio?
    Simply Wall St.

    Do You Like Henry Schein, Inc. (NASDAQ:HSIC) At This P/E Ratio?

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...

  • Business Wire

    Henry Schein Disaster Relief Hotline Is Open to Support Customers Affected by California Fires

    Henry Schein, Inc. (HSIC) reminds its customers in California that the Henry Schein Disaster Relief Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 7 a.m. to 5 p.m. Central Time.

  • Henry Schein (HSIC) Expected to Beat Earnings Estimates: Should You Buy? (Revised)
    Zacks

    Henry Schein (HSIC) Expected to Beat Earnings Estimates: Should You Buy? (Revised)

    Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Henry Schein Announces $400 Million Increase to Share Repurchase Plan

    Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock. The Company had approximately 147 million shares outstanding as of October 30, 2019. This new authorization represents approximately 4.0 percent of shares outstanding at the current stock price.

  • Can Dental Growth Drive Henry Schein's (HSIC) Q3 Earnings?
    Zacks

    Can Dental Growth Drive Henry Schein's (HSIC) Q3 Earnings?

    The robust performance of the Primescan system in Europe and the United States is expected to have contributed to Henry Schein's (HSIC) top line during Q3.

  • Business Wire

    Henry Schein to Present at the Credit Suisse 2019 Healthcare Conference

    Henry Schein, Inc. , the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the Credit Suisse 2019 Healthcare Conference at The Phoenician in Scottsdale, Arizona, on Tuesday, November 12, 2019, at 9:10 a.m.

  • What's in the Offing for Stryker's (SYK) Earnings in Q3?
    Zacks

    What's in the Offing for Stryker's (SYK) Earnings in Q3?

    Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine and an upbeat third quarter 2019 view are likely to have contributed to Stryker's (SYK) Q3 earnings.

  • Why Henry Schein (HSIC) Could Beat Earnings Estimates Again
    Zacks

    Why Henry Schein (HSIC) Could Beat Earnings Estimates Again

    Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Business Wire

    Henry Schein to Webcast Third Quarter 2019 Conference Call on Tuesday, November 5, 2019, at 10:00 a.m. ET

    Henry Schein, Inc. , the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that it will release its third quarter 2019 financial results before the stock market opens on Tuesday, November 5, 2019, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m.

  • Business Wire

    Henry Schein To Be Dismissed From Summit County Opioid Litigation

    Henry Schein, Inc. (HSIC) announced today that the plaintiff has agreed to dismiss the Company with prejudice as a defendant in the opioid litigation involving Summit County, Ohio, presently before the U.S. District Court for the Northern District of Ohio. “The opioid crisis is a terrible national tragedy, and all segments of society need to come together to address the crisis,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. “We look forward to playing a constructive role in helping to advance solutions that put an end to opioid addiction.

  • Business Wire

    U.S. Federal Trade Commission Judge Dismisses Claims Against Henry Schein

    Henry Schein, Inc. (HSIC) issued the following statement in response to a ruling released today by D. Michael Chappell, the Chief Administrative Law Judge of the U.S. Federal Trade Commission (link to decision), who dismissed claims that Henry Schein conspired with competitors to avoid providing discounts to, or to otherwise serve, buying groups representing dental practitioners. Henry Schein, Inc. (HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes.

  • Henry Schein Chairman and CEO Stanley M. Bergman Receives the National Network for Oral Health Access President’s Award
    Business Wire

    Henry Schein Chairman and CEO Stanley M. Bergman Receives the National Network for Oral Health Access President’s Award

    Henry Schein, Inc. (HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the National Network for Oral Health Access (NNOHA) President’s Award for his support of NNOHA as well as his personal, professional, and humanitarian accomplishments. Under Mr. Bergman’s leadership, Henry Schein played a pivotal role in helping to develop the organization during its inception in 1991. Mr. Bergman has continued to be a thought leader for inclusive health by recognizing the importance of NNOHA at its founding and supporting its goal of strengthening and expanding the nation’s oral health safety-net system.

  • Here's Why You Should Retain Henry Schein (HSIC) Stock Now
    Zacks

    Here's Why You Should Retain Henry Schein (HSIC) Stock Now

    Investor confidence is still high on Henry Schein (HSIC), thanks to solid prospects.

  • Reuters - UK Focus

    UPDATE 2-U.S. appeals court will not disqualify judge in opioid cases or delay trial

    A federal appeals court on Thursday cleared the way for a landmark trial over the nation's opioid crisis, rejecting a bid by eight drug retailers and distributors to disqualify the judge, and a request by Ohio and other U.S. states to delay an Oct. 21 trial. The 6th U.S. Circuit Court of Appeals in Cincinnati said U.S. District Judge Dan Polster, who oversees nationwide opioid litigation, had not created an appearance of bias against the drug industry through his rulings, public statements, and efforts to encourage settlements.

  • Did Henry Schein, Inc. (NASDAQ:HSIC) Insiders Sell Shares?
    Simply Wall St.

    Did Henry Schein, Inc. (NASDAQ:HSIC) Insiders Sell Shares?

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

  • Reuters - UK Focus

    Drug companies urge appeals court to remove judge from U.S. opioid litigation

    Eight drug companies on Tuesday urged a federal appeals court to disqualify the judge overseeing nationwide opioid litigation, in a last-ditch effort to avoid having him preside over a landmark trial in three weeks. The request came six days after U.S. District Judge Dan Polster in Cleveland refused to recuse himself and said he had done nothing to favor the state and local governments suing for damages, including by encouraging settlements. Polster oversees more than 2,300 of the roughly 2,600 lawsuits brought by state, local and tribal governments, hospitals and other entities seeking to hold the drug industry responsible for the toll of opioid abuse.

  • Reuters - UK Focus

    UPDATE 4-U.S. judge refuses to disqualify himself from opioid litigation

    The U.S. judge overseeing nationwide opioid litigation on Thursday rejected a request by several big pharmacy chains and drug distributors to disqualify himself because he appeared to be biased against them and pressed too hard for a costly settlement. Companies that sought Polster's recusal included retailers CVS Health Corp, Rite Aid Corp, Walgreens Boots Alliance Inc and Walmart Inc, and distributors AmerisourceBergen Corp, Cardinal Health Inc, Henry Schein Inc and McKesson Corp.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more